Mina is an assistant professor at the Leslie Dan Faculty of Pharmacy at the University of He is also a Scientist, investigator with the Ontario Drug Policy Research Network (ODPRN) and ICES adjunct scientist. He completed a PhD in pharmacoepidemiology at the University of Toronto and previously completed a Masters in Health Outcomes and Policy Research at the University of Tennessee, and a Doctor of Pharmacy at Albany College of Pharmacy. He also completed a pharmacy residency in Drug Information and Health Outcomes at the University of Tennessee and St. Jude Children’s Research Hospital. Mina leads research focused on evaluating drug policies and post-marketing surveillance of medications. He works closely with policymakers and uses large data sets to answer questions about medication real-world safety and effectiveness and improving the optimal use of medications.
Day 1 Oct 28, 2025
Day 2 Oct 29, 2025
9:30 am
PANEL
Enabling Robust Supply Chains for Smoother Drug Access
Ensuring robust pharmaceutical supply chains is essential for maintaining consistent drug availability and safeguarding public health. Develop key strategies to enhance your supply chain resilience. Source your plan of action by:
- Diversifying manufacturing and sourcing, including shifting towards options such as local production.
- Enhancing supply chain visibility and transparency.
- Evaluating policy and guidance on supply and stockpiling.
Impact key challenges facing the supply chain to enhance resilience, streamline operations, and ensure consistent drug availability.